National Competitors

GEGR Stock  USD 0.0007  0.00  0.00%   
Analyzing National Health competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of National Health to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out National Health Correlation with its peers.

National Health vs Evolution Technology Correlation

Pay attention - limited upside

The correlation between National Health Scan and ETKR is -1.0 (i.e., Pay attention - limited upside) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding National Health Scan and ETKR in the same portfolio, assuming nothing else is changed.

Moving against National Pink Sheet

  1.0CMDKF CMDKFPairCorr
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.000.00070.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.00060.00
Details
Naive
Forecast
LowNextHigh
0.00070.00070.0007
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00070.00070.0007
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as National Health. Your research has to be compared to or analyzed against National Health's peers to derive any actionable benefits. When done correctly, National Health's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in National Health Scan.

National Health Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between National Health and its competitors represents the degree of relationship between the price movements of corresponding pink sheets. A correlation of about +1.0 implies that the price of National and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of National Health Scan does not affect the price movement of the other competitor.

High positive correlations

KGHIFDEI
MCNOFDEI
ETKRFDEI
MCNOKGHI
ETKRKGHI
ETKRMCNO
  

High negative correlations

ETKRMLCG
ETKRTFRY
MLCGTFRY
ETKRBWVI
TFRYBWVI
ETKRSKVY

Risk-Adjusted Indicators

There is a big difference between National Pink Sheet performing well and National Health Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze National Health's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
FDEI  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
KGHI  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
MCNO  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
HSFI  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
GFCI  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
SKVY  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
BWVI  30.62  13.77  0.00 (0.71) 0.00 
 0.00 
 583.33 
TFRY  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
MLCG  5.95  1.23  0.00  1.60  0.00 
 0.00 
 150.00 
ETKR  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 

National Health Competitive Analysis

The better you understand National Health competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, National Health's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across National Health's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
GEGR FDEI KGHI MCNO BWVI MLCG ETKR
 0.00 
 0.0007 
National
 0.000003 
 0.0001 
Fidelis
 0.00 
 0.0001 
Kaiser
 0.00 
 0.0001 
Mucinno
 33.33 
 0.0004 
Blue
 0.00 
 0.0001 
MLCG
 0.00 
 0.0001 
Evolution
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Current Valuation
Operating Margin
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Annual Yield
Total Debt
Return On Equity
Z Score
Book Value Per Share
Return On Asset
Current Liabilities
Total Asset
Debt To Equity
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Relative Strength Index
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Standard Deviation
Kurtosis
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Information Ratio

National Health Competition Performance Charts

Five steps to successful analysis of National Health Competition

National Health's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by National Health Scan in relation to its competition. National Health's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of National Health in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact National Health's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to National Health Scan, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your National Health position

In addition to having National Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Hybrid Mix Funds Thematic Idea Now

Hybrid Mix Funds
Hybrid Mix Funds Theme
Funds or Etfs that are made of portfolios of stocks, bonds, or cash instruments with different maturity horizons and characteristics. The Hybrid Mix Funds theme has 39 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Hybrid Mix Funds Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for National Pink Sheet Analysis

When running National Health's price analysis, check to measure National Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy National Health is operating at the current time. Most of National Health's value examination focuses on studying past and present price action to predict the probability of National Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move National Health's price. Additionally, you may evaluate how the addition of National Health to your portfolios can decrease your overall portfolio volatility.